| Code | 02124 | ||||||||||
| MA number | 44/0840/10-S | ||||||||||
| Product Form: | con inf 5x5 ml/200 mg (liek.inj.skl. + ochr.obal) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(3) hybrid application |
| MA issued: | 25.11.2010 |
| SPC: |
SPC_Gemliquid 40 mg_ml_09.2024.pdf
|
| PIL: |
PIL_Gemliquid 40 mg_ml_09.2024.pdf
|
| Safety feature | Yes |
| Data update: | 21.01.2021 |
